1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Monotherapy
        1.2.3 Combination Therapy
    1.3 Market by Application
        1.3.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Acute Leukemia
        1.3.3 Non-hodgkin's Lymphoma
        1.3.4 Multiple Myeloma
        1.3.5 Transplant Rejection
        1.3.6 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Chimeric Antigen Receptor Cell Therapy Market Perspective (2017-2028)
    2.2 Chimeric Antigen Receptor Cell Therapy Growth Trends by Region
        2.2.1 Chimeric Antigen Receptor Cell Therapy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Chimeric Antigen Receptor Cell Therapy Historic Market Size by Region (2017-2022)
        2.2.3 Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Region (2023-2028)
    2.3 Chimeric Antigen Receptor Cell Therapy Market Dynamics
        2.3.1 Chimeric Antigen Receptor Cell Therapy Industry Trends
        2.3.2 Chimeric Antigen Receptor Cell Therapy Market Drivers
        2.3.3 Chimeric Antigen Receptor Cell Therapy Market Challenges
        2.3.4 Chimeric Antigen Receptor Cell Therapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Chimeric Antigen Receptor Cell Therapy Players by Revenue
        3.1.1 Global Top Chimeric Antigen Receptor Cell Therapy Players by Revenue (2017-2022)
        3.1.2 Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Players (2017-2022)
    3.2 Global Chimeric Antigen Receptor Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Chimeric Antigen Receptor Cell Therapy Revenue
    3.4 Global Chimeric Antigen Receptor Cell Therapy Market Concentration Ratio
        3.4.1 Global Chimeric Antigen Receptor Cell Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Chimeric Antigen Receptor Cell Therapy Revenue in 2021
    3.5 Chimeric Antigen Receptor Cell Therapy Key Players Head office and Area Served
    3.6 Key Players Chimeric Antigen Receptor Cell Therapy Product Solution and Service
    3.7 Date of Enter into Chimeric Antigen Receptor Cell Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Chimeric Antigen Receptor Cell Therapy Breakdown Data by Type
    4.1 Global Chimeric Antigen Receptor Cell Therapy Historic Market Size by Type (2017-2022)
    4.2 Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Type (2023-2028)
5 Chimeric Antigen Receptor Cell Therapy Breakdown Data by Application
    5.1 Global Chimeric Antigen Receptor Cell Therapy Historic Market Size by Application (2017-2022)
    5.2 Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Chimeric Antigen Receptor Cell Therapy Market Size (2017-2028)
    6.2 North America Chimeric Antigen Receptor Cell Therapy Market Size by Type
        6.2.1 North America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022)
        6.2.2 North America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028)
        6.2.3 North America Chimeric Antigen Receptor Cell Therapy Market Share by Type (2017-2028)
    6.3 North America Chimeric Antigen Receptor Cell Therapy Market Size by Application
        6.3.1 North America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022)
        6.3.2 North America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028)
        6.3.3 North America Chimeric Antigen Receptor Cell Therapy Market Share by Application (2017-2028)
    6.4 North America Chimeric Antigen Receptor Cell Therapy Market Size by Country
        6.4.1 North America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2017-2022)
        6.4.2 North America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size (2017-2028)
    7.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type
        7.2.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022)
        7.2.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028)
        7.2.3 Europe Chimeric Antigen Receptor Cell Therapy Market Share by Type (2017-2028)
    7.3 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application
        7.3.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022)
        7.3.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028)
        7.3.3 Europe Chimeric Antigen Receptor Cell Therapy Market Share by Application (2017-2028)
    7.4 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country
        7.4.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2017-2022)
        7.4.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size (2017-2028)
    8.2 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Type
        8.2.1 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Share by Type (2017-2028)
    8.3 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Application
        8.3.1 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Share by Application (2017-2028)
    8.4 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region
        8.4.1 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Chimeric Antigen Receptor Cell Therapy Market Size (2017-2028)
    9.2 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Type
        9.2.1 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022)
        9.2.2 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028)
        9.2.3 Latin America Chimeric Antigen Receptor Cell Therapy Market Share by Type (2017-2028)
    9.3 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Application
        9.3.1 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022)
        9.3.2 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028)
        9.3.3 Latin America Chimeric Antigen Receptor Cell Therapy Market Share by Application (2017-2028)
    9.4 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Country
        9.4.1 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2017-2022)
        9.4.2 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size (2017-2028)
    10.2 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type
        10.2.1 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Share by Type (2017-2028)
    10.3 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application
        10.3.1 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Share by Application (2017-2028)
    10.4 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Country
        10.4.1 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Amgen Inc
        11.1.1 Amgen Inc Company Details
        11.1.2 Amgen Inc Business Overview
        11.1.3 Amgen Inc Chimeric Antigen Receptor Cell Therapy Introduction
        11.1.4 Amgen Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.1.5 Amgen Inc Recent Developments
    11.2 Autolus Therapeutics Plc
        11.2.1 Autolus Therapeutics Plc Company Details
        11.2.2 Autolus Therapeutics Plc Business Overview
        11.2.3 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Introduction
        11.2.4 Autolus Therapeutics Plc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.2.5 Autolus Therapeutics Plc Recent Developments
    11.3 Beijing Immunochina Medical Science & Technology Co Ltd
        11.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Details
        11.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Business Overview
        11.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
        11.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Recent Developments
    11.4 Bellicum Pharmaceuticals Inc
        11.4.1 Bellicum Pharmaceuticals Inc Company Details
        11.4.2 Bellicum Pharmaceuticals Inc Business Overview
        11.4.3 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Introduction
        11.4.4 Bellicum Pharmaceuticals Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.4.5 Bellicum Pharmaceuticals Inc Recent Developments
    11.5 Bristol-Myers Squibb Co
        11.5.1 Bristol-Myers Squibb Co Company Details
        11.5.2 Bristol-Myers Squibb Co Business Overview
        11.5.3 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Introduction
        11.5.4 Bristol-Myers Squibb Co Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.5.5 Bristol-Myers Squibb Co Recent Developments
    11.6 bluebird bio Inc
        11.6.1 bluebird bio Inc Company Details
        11.6.2 bluebird bio Inc Business Overview
        11.6.3 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Introduction
        11.6.4 bluebird bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.6.5 bluebird bio Inc Recent Developments
    11.7 CARsgen Therapeutics Ltd
        11.7.1 CARsgen Therapeutics Ltd Company Details
        11.7.2 CARsgen Therapeutics Ltd Business Overview
        11.7.3 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Introduction
        11.7.4 CARsgen Therapeutics Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.7.5 CARsgen Therapeutics Ltd Recent Developments
    11.8 Celgene Corp
        11.8.1 Celgene Corp Company Details
        11.8.2 Celgene Corp Business Overview
        11.8.3 Celgene Corp Chimeric Antigen Receptor Cell Therapy Introduction
        11.8.4 Celgene Corp Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.8.5 Celgene Corp Recent Developments
    11.9 Cell Medica Ltd
        11.9.1 Cell Medica Ltd Company Details
        11.9.2 Cell Medica Ltd Business Overview
        11.9.3 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Introduction
        11.9.4 Cell Medica Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.9.5 Cell Medica Ltd Recent Developments
    11.10 Cellular Biomedicine Group Inc
        11.10.1 Cellular Biomedicine Group Inc Company Details
        11.10.2 Cellular Biomedicine Group Inc Business Overview
        11.10.3 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Introduction
        11.10.4 Cellular Biomedicine Group Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.10.5 Cellular Biomedicine Group Inc Recent Developments
    11.11 Celularity Inc
        11.11.1 Celularity Inc Company Details
        11.11.2 Celularity Inc Business Overview
        11.11.3 Celularity Inc Chimeric Antigen Receptor Cell Therapy Introduction
        11.11.4 Celularity Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.11.5 Celularity Inc Recent Developments
    11.12 Celyad SA
        11.12.1 Celyad SA Company Details
        11.12.2 Celyad SA Business Overview
        11.12.3 Celyad SA Chimeric Antigen Receptor Cell Therapy Introduction
        11.12.4 Celyad SA Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.12.5 Celyad SA Recent Developments
    11.13 Daiichi Sankyo Co Ltd
        11.13.1 Daiichi Sankyo Co Ltd Company Details
        11.13.2 Daiichi Sankyo Co Ltd Business Overview
        11.13.3 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
        11.13.4 Daiichi Sankyo Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.13.5 Daiichi Sankyo Co Ltd Recent Developments
    11.14 Fosun Pharmaceutical AG
        11.14.1 Fosun Pharmaceutical AG Company Details
        11.14.2 Fosun Pharmaceutical AG Business Overview
        11.14.3 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Introduction
        11.14.4 Fosun Pharmaceutical AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.14.5 Fosun Pharmaceutical AG Recent Developments
    11.15 Gilead Sciences Inc
        11.15.1 Gilead Sciences Inc Company Details
        11.15.2 Gilead Sciences Inc Business Overview
        11.15.3 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Introduction
        11.15.4 Gilead Sciences Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.15.5 Gilead Sciences Inc Recent Developments
    11.16 Guangzhou Anjie Biomedical Technology Co Ltd
        11.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Details
        11.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
        11.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
        11.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Recent Developments
    11.17 Hangzhou Converd Co Ltd
        11.17.1 Hangzhou Converd Co Ltd Company Details
        11.17.2 Hangzhou Converd Co Ltd Business Overview
        11.17.3 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
        11.17.4 Hangzhou Converd Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.17.5 Hangzhou Converd Co Ltd Recent Developments
    11.18 Hebei Senlang Biotechnology Inc Ltd
        11.18.1 Hebei Senlang Biotechnology Inc Ltd Company Details
        11.18.2 Hebei Senlang Biotechnology Inc Ltd Business Overview
        11.18.3 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Introduction
        11.18.4 Hebei Senlang Biotechnology Inc Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.18.5 Hebei Senlang Biotechnology Inc Ltd Recent Developments
    11.19 HRAIN Biotechnology Co Ltd
        11.19.1 HRAIN Biotechnology Co Ltd Company Details
        11.19.2 HRAIN Biotechnology Co Ltd Business Overview
        11.19.3 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
        11.19.4 HRAIN Biotechnology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.19.5 HRAIN Biotechnology Co Ltd Recent Developments
    11.20 Juno Therapeutics Inc
        11.20.1 Juno Therapeutics Inc Company Details
        11.20.2 Juno Therapeutics Inc Business Overview
        11.20.3 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Introduction
        11.20.4 Juno Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.20.5 Juno Therapeutics Inc Recent Developments
    11.21 Kite Pharma Inc
        11.21.1 Kite Pharma Inc Company Details
        11.21.2 Kite Pharma Inc Business Overview
        11.21.3 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Introduction
        11.21.4 Kite Pharma Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.21.5 Kite Pharma Inc Recent Developments
    11.22 Nanjing Legend Biotech Co Ltd
        11.22.1 Nanjing Legend Biotech Co Ltd Company Details
        11.22.2 Nanjing Legend Biotech Co Ltd Business Overview
        11.22.3 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
        11.22.4 Nanjing Legend Biotech Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.22.5 Nanjing Legend Biotech Co Ltd Recent Developments
    11.23 NantKwest Inc
        11.23.1 NantKwest Inc Company Details
        11.23.2 NantKwest Inc Business Overview
        11.23.3 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Introduction
        11.23.4 NantKwest Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.23.5 NantKwest Inc Recent Developments
    11.24 Nkarta Inc
        11.24.1 Nkarta Inc Company Details
        11.24.2 Nkarta Inc Business Overview
        11.24.3 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Introduction
        11.24.4 Nkarta Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.24.5 Nkarta Inc Recent Developments
    11.25 Novartis AG
        11.25.1 Novartis AG Company Details
        11.25.2 Novartis AG Business Overview
        11.25.3 Novartis AG Chimeric Antigen Receptor Cell Therapy Introduction
        11.25.4 Novartis AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.25.5 Novartis AG Recent Developments
    11.26 Ono Pharmaceutical Co Ltd
        11.26.1 Ono Pharmaceutical Co Ltd Company Details
        11.26.2 Ono Pharmaceutical Co Ltd Business Overview
        11.26.3 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
        11.26.4 Ono Pharmaceutical Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.26.5 Ono Pharmaceutical Co Ltd Recent Developments
    11.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
        11.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details
        11.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
        11.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
        11.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Developments
    11.28 Sorrento Therapeutics Inc
        11.28.1 Sorrento Therapeutics Inc Company Details
        11.28.2 Sorrento Therapeutics Inc Business Overview
        11.28.3 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Introduction
        11.28.4 Sorrento Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.28.5 Sorrento Therapeutics Inc Recent Developments
    11.29 Takara Bio Inc
        11.29.1 Takara Bio Inc Company Details
        11.29.2 Takara Bio Inc Business Overview
        11.29.3 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Introduction
        11.29.4 Takara Bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
        11.29.5 Takara Bio Inc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Monotherapy
    Table 3. Key Players of Combination Therapy
    Table 4. Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Chimeric Antigen Receptor Cell Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Chimeric Antigen Receptor Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Chimeric Antigen Receptor Cell Therapy Market Share by Region (2017-2022)
    Table 8. Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Chimeric Antigen Receptor Cell Therapy Market Share by Region (2023-2028)
    Table 10. Chimeric Antigen Receptor Cell Therapy Market Trends
    Table 11. Chimeric Antigen Receptor Cell Therapy Market Drivers
    Table 12. Chimeric Antigen Receptor Cell Therapy Market Challenges
    Table 13. Chimeric Antigen Receptor Cell Therapy Market Restraints
    Table 14. Global Chimeric Antigen Receptor Cell Therapy Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Chimeric Antigen Receptor Cell Therapy Revenue Share by Players (2017-2022)
    Table 16. Global Top Chimeric Antigen Receptor Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor Cell Therapy as of 2021)
    Table 17. Ranking of Global Top Chimeric Antigen Receptor Cell Therapy Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Chimeric Antigen Receptor Cell Therapy Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Chimeric Antigen Receptor Cell Therapy Product Solution and Service
    Table 21. Date of Enter into Chimeric Antigen Receptor Cell Therapy Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Type (2017-2022)
    Table 25. Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Type (2023-2028)
    Table 27. Global Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Chimeric Antigen Receptor Cell Therapy Revenue Share by Application (2017-2022)
    Table 29. Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Chimeric Antigen Receptor Cell Therapy Revenue Share by Application (2023-2028)
    Table 31. North America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Amgen Inc Company Details
    Table 62. Amgen Inc Business Overview
    Table 63. Amgen Inc Chimeric Antigen Receptor Cell Therapy Product
    Table 64. Amgen Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 65. Amgen Inc Recent Developments
    Table 66. Autolus Therapeutics Plc Company Details
    Table 67. Autolus Therapeutics Plc Business Overview
    Table 68. Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Product
    Table 69. Autolus Therapeutics Plc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 70. Autolus Therapeutics Plc Recent Developments
    Table 71. Beijing Immunochina Medical Science & Technology Co Ltd Company Details
    Table 72. Beijing Immunochina Medical Science & Technology Co Ltd Business Overview
    Table 73. Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product
    Table 74. Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 75. Beijing Immunochina Medical Science & Technology Co Ltd Recent Developments
    Table 76. Bellicum Pharmaceuticals Inc Company Details
    Table 77. Bellicum Pharmaceuticals Inc Business Overview
    Table 78. Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Product
    Table 79. Bellicum Pharmaceuticals Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 80. Bellicum Pharmaceuticals Inc Recent Developments
    Table 81. Bristol-Myers Squibb Co Company Details
    Table 82. Bristol-Myers Squibb Co Business Overview
    Table 83. Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Product
    Table 84. Bristol-Myers Squibb Co Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 85. Bristol-Myers Squibb Co Recent Developments
    Table 86. bluebird bio Inc Company Details
    Table 87. bluebird bio Inc Business Overview
    Table 88. bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Product
    Table 89. bluebird bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 90. bluebird bio Inc Recent Developments
    Table 91. CARsgen Therapeutics Ltd Company Details
    Table 92. CARsgen Therapeutics Ltd Business Overview
    Table 93. CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Product
    Table 94. CARsgen Therapeutics Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 95. CARsgen Therapeutics Ltd Recent Developments
    Table 96. Celgene Corp Company Details
    Table 97. Celgene Corp Business Overview
    Table 98. Celgene Corp Chimeric Antigen Receptor Cell Therapy Product
    Table 99. Celgene Corp Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 100. Celgene Corp Recent Developments
    Table 101. Cell Medica Ltd Company Details
    Table 102. Cell Medica Ltd Business Overview
    Table 103. Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Product
    Table 104. Cell Medica Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 105. Cell Medica Ltd Recent Developments
    Table 106. Cellular Biomedicine Group Inc Company Details
    Table 107. Cellular Biomedicine Group Inc Business Overview
    Table 108. Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Product
    Table 109. Cellular Biomedicine Group Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 110. Cellular Biomedicine Group Inc Recent Developments
    Table 111. Celularity Inc Company Details
    Table 112. Celularity Inc Business Overview
    Table 113. Celularity Inc Chimeric Antigen Receptor Cell Therapy Product
    Table 114. Celularity Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 115. Celularity Inc Recent Developments
    Table 116. Celyad SA Company Details
    Table 117. Celyad SA Business Overview
    Table 118. Celyad SA Chimeric Antigen Receptor Cell Therapy Product
    Table 119. Celyad SA Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 120. Celyad SA Recent Developments
    Table 121. Daiichi Sankyo Co Ltd Company Details
    Table 122. Daiichi Sankyo Co Ltd Business Overview
    Table 123. Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Product
    Table 124. Daiichi Sankyo Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 125. Daiichi Sankyo Co Ltd Recent Developments
    Table 126. Fosun Pharmaceutical AG Company Details
    Table 127. Fosun Pharmaceutical AG Business Overview
    Table 128. Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Product
    Table 129. Fosun Pharmaceutical AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 130. Fosun Pharmaceutical AG Recent Developments
    Table 131. Gilead Sciences Inc Company Details
    Table 132. Gilead Sciences Inc Business Overview
    Table 133. Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Product
    Table 134. Gilead Sciences Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 135. Gilead Sciences Inc Recent Developments
    Table 136. Guangzhou Anjie Biomedical Technology Co Ltd Company Details
    Table 137. Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
    Table 138. Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product
    Table 139. Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 140. Guangzhou Anjie Biomedical Technology Co Ltd Recent Developments
    Table 141. Hangzhou Converd Co Ltd Company Details
    Table 142. Hangzhou Converd Co Ltd Business Overview
    Table 143. Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Product
    Table 144. Hangzhou Converd Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 145. Hangzhou Converd Co Ltd Recent Developments
    Table 146. Hebei Senlang Biotechnology Inc Ltd Company Details
    Table 147. Hebei Senlang Biotechnology Inc Ltd Business Overview
    Table 148. Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Product
    Table 149. Hebei Senlang Biotechnology Inc Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 150. Hebei Senlang Biotechnology Inc Ltd Recent Developments
    Table 151. HRAIN Biotechnology Co Ltd Company Details
    Table 152. HRAIN Biotechnology Co Ltd Business Overview
    Table 153. HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Product
    Table 154. HRAIN Biotechnology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 155. HRAIN Biotechnology Co Ltd Recent Developments
    Table 156. Juno Therapeutics Inc Company Details
    Table 157. Juno Therapeutics Inc Business Overview
    Table 158. Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product
    Table 159. Juno Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 160. Juno Therapeutics Inc Recent Developments
    Table 161. Kite Pharma Inc Company Details
    Table 162. Kite Pharma Inc Business Overview
    Table 163. Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Product
    Table 164. Kite Pharma Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 165. Kite Pharma Inc Recent Developments
    Table 166. Nanjing Legend Biotech Co Ltd Company Details
    Table 167. Nanjing Legend Biotech Co Ltd Business Overview
    Table 168. Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Product
    Table 169. Nanjing Legend Biotech Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 170. Nanjing Legend Biotech Co Ltd Recent Developments
    Table 171. NantKwest Inc Company Details
    Table 172. NantKwest Inc Business Overview
    Table 173. NantKwest Inc Chimeric Antigen Receptor Cell Therapy Product
    Table 174. NantKwest Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 175. NantKwest Inc Recent Developments
    Table 176. Nkarta Inc Company Details
    Table 177. Nkarta Inc Business Overview
    Table 178. Nkarta Inc Chimeric Antigen Receptor Cell Therapy Product
    Table 179. Nkarta Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 180. Nkarta Inc Recent Developments
    Table 181. Novartis AG Company Details
    Table 182. Novartis AG Business Overview
    Table 183. Novartis AG Chimeric Antigen Receptor Cell Therapy Product
    Table 184. Novartis AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 185. Novartis AG Recent Developments
    Table 186. Ono Pharmaceutical Co Ltd Company Details
    Table 187. Ono Pharmaceutical Co Ltd Business Overview
    Table 188. Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Product
    Table 189. Ono Pharmaceutical Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 190. Ono Pharmaceutical Co Ltd Recent Developments
    Table 191. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details
    Table 192. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
    Table 193. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product
    Table 194. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 195. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Developments
    Table 196. Sorrento Therapeutics Inc Company Details
    Table 197. Sorrento Therapeutics Inc Business Overview
    Table 198. Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product
    Table 199. Sorrento Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 200. Sorrento Therapeutics Inc Recent Developments
    Table 201. Takara Bio Inc Company Details
    Table 202. Takara Bio Inc Business Overview
    Table 203. Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Product
    Table 204. Takara Bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
    Table 205. Takara Bio Inc Recent Developments
    Table 206. Research Programs/Design for This Report
    Table 207. Key Data Information from Secondary Sources
    Table 208. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Chimeric Antigen Receptor Cell Therapy Market Share by Type: 2021 VS 2028
    Figure 2. Monotherapy Features
    Figure 3. Combination Therapy Features
    Figure 4. Global Chimeric Antigen Receptor Cell Therapy Market Share by Application: 2021 VS 2028
    Figure 5. Acute Leukemia Case Studies
    Figure 6. Non-hodgkin's Lymphoma Case Studies
    Figure 7. Multiple Myeloma Case Studies
    Figure 8. Transplant Rejection Case Studies
    Figure 9. Other Case Studies
    Figure 10. Chimeric Antigen Receptor Cell Therapy Report Years Considered
    Figure 11. Global Chimeric Antigen Receptor Cell Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Chimeric Antigen Receptor Cell Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Chimeric Antigen Receptor Cell Therapy Market Share by Region: 2021 VS 2028
    Figure 14. Global Chimeric Antigen Receptor Cell Therapy Market Share by Players in 2021
    Figure 15. Global Top Chimeric Antigen Receptor Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor Cell Therapy as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Chimeric Antigen Receptor Cell Therapy Revenue in 2021
    Figure 17. North America Chimeric Antigen Receptor Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2017-2028)
    Figure 19. North America Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2017-2028)
    Figure 20. North America Chimeric Antigen Receptor Cell Therapy Market Size Share by Country (2017-2028)
    Figure 21. United States Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Chimeric Antigen Receptor Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Chimeric Antigen Receptor Cell Therapy Market Size Share by Country (2017-2028)
    Figure 27. Germany Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size Share by Region (2017-2028)
    Figure 37. China Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Chimeric Antigen Receptor Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Chimeric Antigen Receptor Cell Therapy Market Size Share by Country (2017-2028)
    Figure 47. Mexico Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size Share by Country (2017-2028)
    Figure 53. Turkey Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Amgen Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 57. Autolus Therapeutics Plc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 58. Beijing Immunochina Medical Science & Technology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 59. Bellicum Pharmaceuticals Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 60. Bristol-Myers Squibb Co Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 61. bluebird bio Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 62. CARsgen Therapeutics Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 63. Celgene Corp Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 64. Cell Medica Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 65. Cellular Biomedicine Group Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 66. Celularity Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 67. Celyad SA Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 68. Daiichi Sankyo Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 69. Fosun Pharmaceutical AG Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 70. Gilead Sciences Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 71. Guangzhou Anjie Biomedical Technology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 72. Hangzhou Converd Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 73. Hebei Senlang Biotechnology Inc Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 74. HRAIN Biotechnology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 75. Juno Therapeutics Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 76. Kite Pharma Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 77. Nanjing Legend Biotech Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 78. NantKwest Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 79. Nkarta Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 80. Novartis AG Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 81. Ono Pharmaceutical Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 82. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 83. Sorrento Therapeutics Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 84. Takara Bio Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed